Viewing Study NCT00940758


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2026-03-02 @ 8:19 AM
Study NCT ID: NCT00940758
Status: COMPLETED
Last Update Posted: 2017-04-06
First Post: 2009-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I and Pharmacokinetic Study of Biweekly PEP02 in mCRC Refractory to 1st-line Oxaliplatin Base Therapy
Sponsor: PharmaEngine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module